November 18, 2008 (Washington, DC) — The use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) is significantly associated with lower levels of prostate-specific antigen (PSA).

Hemodilution from increased circulating plasma volumes could explain why obese men with prostate cancer have lower serum PSA levels than non-obese men with the malignancy, according to researchers. A ...

It may be appropriate to drop cutpoint from 4.0 to 2.0-2.5 ng/mL in men younger than 50 years. Diagnostic PSA levels in men younger than 50 years are significantly lower than guidelines suggest, ...

SAN ANTONIO — Veterans Administration (VA) medical centers with lower prostate-specific antigen (PSA) screening rates reported higher rates of metastatic prostate cancer, a recent retrospective ...

NEW YORK (Reuters Health) - On average, men's levels of prostate-specific antigen (PSA) decrease as their body mass index (BMI) rises, a new study shows. PSA is a marker for prostate cancer risk when ...

For more than 20 years, the prostate-specific antigen (PSA) test has been used to help screen for prostate cancer, but in recent years, some task forces have called for this blood test to be abandoned ...

Black men in the United States are more likely to develop prostate cancer than white men, and after diagnosis, they're more likely to have advanced disease and to die than white men with the disease.

Please provide your email address to receive an email when new articles are posted on . At any given PSA level, Black men are more likely than white men to harbor prostate cancer, according to ...

Prostate-specific antigen (PSA) is a protein made by the prostate gland. A high PSA level could be a sign of an enlarged prostate, inflammation called prostatitis, or prostate cancer. The PSA test ...

Black men in the United States are more likely to develop prostate cancer than white men, and after diagnosis, they’re more likely to have advanced disease and to die than white men with the disease.